Technip Energies announces end of share buy-back program
Get Alerts TE Hot Sheet
Join SI Premium – FREE
Technip Energies (PARIS:TE) (the “Company”) announces the completion of its share buy-back program, which launch was announced in a press release dated March 18, 2026.
Between March 18, 2026, and June 30, 2026, the Company acquired 4,246,851 of its own shares (representing 2.38% of the share capital), at an average price per share of 36.64 euros.
As announced in the press release dated March 18, 2026, the shares acquired under the share buy-back program will be used for the following purposes: 1. to reduce the Company’s share capital by cancelling treasury shares; 2. to meet the Company's obligations under equity incentive plans.
Details of the transactions carried out under this share buy-back program are available on the Company's website: https://investors.technipenergies.com/financial-information/publications-regulated-information/notice-trading-own-shares.
The liquidity agreement resumed on July 1st, 2026.
About Technip Energies
Technip Energies is a global technology and engineering powerhouse. With leadership positions in LNG, hydrogen, ethylene, sustainable chemistry, and CO2 management, we are contributing to the development of critical markets such as energy, energy derivatives, decarbonization, and circularity. Our complementary business segments, Technology, Products and Services (TPS) and Project Delivery, turn innovation into scalable and industrial reality.
Through collaboration and excellence in execution, our 18,000+ employees across 35 countries are fully committed to bridging prosperity with sustainability for a world designed to last.
Technip Energies generated revenues of €7.2 billion in 2025 and is listed on Euronext Paris. The Company also has American Depositary Receipts trading over the counter.
For further information: www.ten.com
Contacts
| Investor Relations | Media Relations |
| Phillip Lindsay | Jason Hyonne |
| Vice-President Investor Relations | Press Relations & Social Media Manager |
| Tel: +44 207 585 5051 | Tel: +33 1 47 78 22 89 |
| Email: Phillip Lindsay | Email: Jason Hyonne |
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
- From Lab to Life: How AI Works in China, Available August 4, Examines the Governance System Behind China's AI Industry
- Wuyi County Highlights Industrial R&D Strength as Local Motorcycle Enterprise Wins Taklimakan Rally Champion Title
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share